0
Sign In  | Subscribe

Coronary Risk Factors Collection
 41-60 of 164 Articles
ACP Journal Club |  18 October 2011
A personalized, cellular phone text-messaging program increased smoking cessation at 6 months
PDFPDF
Charles J. Bentz, MD, FACP
Ann Intern Med. 2011;155(8):JC4-4. doi:10.7326/0003-4819-155-8-201110180-02004
ACP Journal Club |  18 October 2011
Review: Varenicline increases risk for serious adverse cardiovascular events in tobacco users
PDFPDF
James M. Brophy, MD, PhD
Ann Intern Med. 2011;155(8):JC4-5. doi:10.7326/0003-4819-155-8-201110180-02005
ACP Journal Club |  18 October 2011
Review: Intensive-dose statin therapy increases incident diabetes compared with moderate-dose therapy
PDFPDF
Elizabeth Barrett-Connor, MD
Ann Intern Med. 2011;155(8):JC4-7. doi:10.7326/0003-4819-155-8-201110180-02007
ACP Journal Club |  18 October 2011
Review: Evidence for the effectiveness of interventions to prevent foot ulcers in patients with diabetes is limited
PDFPDF
Dara L. Eckerle Mize, MD; Gunjan Y. Gandhi, MD, MSc
Ann Intern Med. 2011;155(8):JC4-8. doi:10.7326/0003-4819-155-8-201110180-02008
ACP Journal Club |  20 September 2011
Protocol-based nurse management of type 2 diabetes did not differ from usual GP care for HbA1c levels
PDFPDF
Timothy Kenealy, MD, PhD; Nicolette Sheridan, RN, PhD, MPH
Ann Intern Med. 2011;155(6):JC3-7. doi:10.7326/0003-4819-155-6-201109200-02007
ACP Journal Club |  16 August 2011
Calcium plus vitamin D was associated with increased cardiovascular risk in women not taking personal calcium supplements
PDFPDF
Carolyn J. Crandall, MD, MS; Jane A. Cauley, DrPH
Ann Intern Med. 2011;155(4):JC2-3. doi:10.7326/0003-4819-155-4-201108160-02003
ACP Journal Club |  16 August 2011
Review: Oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints
PDFPDF
Juan Pablo Domecq, MD; Gabriela Prutsky, MD; Victor M. Montori, MD
Ann Intern Med. 2011;155(4):JC2-4. doi:10.7326/0003-4819-155-4-201108160-02004
ACP Journal Club |  16 August 2011
Meta-analysis: High-dose statin pretreatment prevents periprocedural cardiac events in patients having PCI
PDFPDF
Emil L. Fosbol, MD, PhD; Christopher B. Granger, MD
Ann Intern Med. 2011;155(4):JC2-8. doi:10.7326/0003-4819-155-4-201108160-02008
ACP Journal Club |  16 August 2011
Review: Rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes
PDFPDF
Prakash Deedwania, MD
Ann Intern Med. 2011;155(4):JC2-12. doi:10.7326/0003-4819-155-4-201108160-02012
ACP Journal Club |  21 June 2011
Review: Counseling and educational methods that target multiple CV risk factors do not reduce mortality in adults without CHD
PDFPDF
Mahesh J. Patel, MD; L. Kristin Newby, MD, MHS
Ann Intern Med. 2011;154(12):JC6-4. doi:10.7326/0003-4819-154-12-201106210-02004
ACP Journal Club |  21 June 2011
Candesartan did not improve clinical or functional outcomes in patients with acute stroke and elevated BP
PDFPDF
Rick Frieden, MD
Ann Intern Med. 2011;154(12):JC6-5. doi:10.7326/0003-4819-154-12-201106210-02005
ACP Journal Club |  21 June 2011
Review: Antihypertensive treatment prevents cardiovascular events and mortality in cardiovascular disease without hypertension
PDFPDF
Jay N. Cohn, MD
Ann Intern Med. 2011;154(12):JC6-6. doi:10.7326/0003-4819-154-12-201106210-02006
ACP Journal Club |  21 June 2011
PPI use in the first trimester was not associated with increased risk for birth defects; PPI use 1 to 4 weeks before conception was
PDFPDF
Rory Windrim, MD
Ann Intern Med. 2011;154(12):JC6-11. doi:10.7326/0003-4819-154-12-201106210-02011
ACP Journal Club |  17 May 2011
Intensive glucose control increased mortality and did not prevent CV events compared with standard glucose control in type 2 diabetes
PDFPDF
Rozalina Grubina, MD; Steven A. Smith, MD
Ann Intern Med. 2011;154(10):JC5-2. doi:10.7326/0003-4819-154-10-201105170-02002
ACP Journal Club |  17 May 2011
Meta-analysis: More intensive statin therapy prevents major vascular events
PDFPDF
Donald A. Smith, MD, MPH, FACP, FNLA, FACE
Ann Intern Med. 2011;154(10):JC5-3. doi:10.7326/0003-4819-154-10-201105170-02003
ACP Journal Club |  17 May 2011
In hemodialysis patients with CHF, adding telmisartan to standard ACE inhibitors reduced CHD mortality and admissions
PDFPDF
Reem Mustafa, MD, MPH; Amit X. Garg, MD, PhD
Ann Intern Med. 2011;154(10):JC5-5. doi:10.7326/0003-4819-154-10-201105170-02005
ACP Journal Club |  17 May 2011
Review: Low-dose hydrochlorothiazide is not as effective as other antihypertensive drugs for reducing ambulatory BP in hypertension?
PDFPDF
Eugene Yang, MD, FACC
Ann Intern Med. 2011;154(10):JC5-8. doi:10.7326/0003-4819-154-10-201105170-02008
ACP Journal Club |  17 May 2011
Prescription omega-3 fatty acids did not prevent recurrent, symptomatic, paroxysmal or persistent atrial fibrillation
PDFPDF
Brian Olshansky, MD
Ann Intern Med. 2011;154(10):JC5-9. doi:10.7326/0003-4819-154-10-201105170-02009
ACP Journal Club |  19 April 2011
Review: Varenicline is better than placebo or bupropion, but not clearly different from the nicotine patch, for smoking abstinence
PDFPDF
James Brophy, MD, PhD
Ann Intern Med. 2011;154(8):JC4-4. doi:10.7326/0003-4819-154-8-201104190-02004
ACP Journal Club |  19 April 2011
HbA1c levels had low sensitivity but high specificity for screening for diabetes
PDFPDF
Lorraine Lipscombe, MD, MSc, FRCPC
Ann Intern Med. 2011;154(8):JC4-9. doi:10.7326/0003-4819-154-8-201104190-02009
Advertisement

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)